Photo INNOVEOX gets Charles Rosier as new Partner and TOTAL EP as first client - Afrik-news.com : Africa news, Maghreb news - The african daily newspaper

INNOVEOX gets Charles Rosier as new Partner and TOTAL EP as first client - Afrik-news.com : Africa news, Maghreb news - The african daily newspaper

INNOVEOX gets Charles Rosier as new Partner and TOTAL EP as first client - Afrik-news.com : Africa news, Maghreb news - The african daily newspaper

To prepare himself for ESCP Europe, charles rosier (Découvrir la page Afrik-news de charles rosier) took additional classes at a prestigious private school named Integrale. Aside from being studious, he is also interested in other things like culture, managing environmentally-friendly activities and extreme sports. He joined BTG Pactual Bank and worked there until 2010 as a partner. In 1991, Charles Rosier completed his scientific degree at Fenelon Sainte-Marie.

Charles Rosier's Programmes on Environmental Consciousness

Carbon dioxide emissions can pollute the air and Innoveox tries hard to minimise this through awareness campaigns concerning the effective usage of resources and pollution-free environment programmes. Charles Rosier invested in MPOWERD, helping the company financially to create lanterns and other energy solutions. With this, MPOWERD delivered these effective solutions to more than 25 poor nations around the planet. Charles Rosier has contributed a lot to solving environmental issues and has helped to develop energy and power sectors, especially in poor countries.

Charles Rosier became a member of BTG Pactual in August 2010. He became a partner at BTG Pactual, an investment bank situated in Latin America. He has been in the industry for 15 years, as an investment banker. Charles Rosier’s very first appointment was at Lehman Brothers in 1996. Later, he moved to UBS Warburg to be the manager for their Debt Capital Market Division in 1997.

The drug project Charles Rosier financed was for the treatment of stroke known to cause spinal cord problems and other related issues. With his determination to contribute to the healthcare industry, he invested in the Mapreg Drug Project. Because of the investment made by him, the organisation was able to conduct studies and give a percentage of their profit to Charles Rosier.

How Charles Rosier Was Educated

In 1996, Charles Rosier's job began at Lehman Brothers, just before he joined UBS Warburg Investment Bank. He finished his secondary schooling at Paris’s Fenelon Sainte-Marie in 1991. Charles Rosier spent two years of extra study in preparation for more French requirements.

Articles